RTW INVESTMENTS, LP — SEC Form 4 filings

SEC reporting owner CIK 1493215. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-23.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2024-01-16 to 2026-07-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kailera Therapeutics, Inc. (KLRA)10% owner11 leg · 500,000 sh · $8,000,0003
Orchestra BioMed Holdings, Inc. (OBIO)10% owner42 legs · 99,900 sh · $275,7011 leg · 32 sh · $1323
ALLURION TECHNOLOGIES, INC. (ALUR)10% owner428
ROCKET PHARMACEUTICALS, INC. (RCKT)Director, 10% owner210
CARGO Therapeutics, Inc. (CRGX)10% owner11

Form 4 filings — RTW INVESTMENTS, LP

FiledFormIssuerReported transactionsSource
2026-07-234ALLURION TECHNOLOGIES, INC. (ALUR)
jointly with WONG RODERICK
Other (J): 209,254 · Other (J): 161,807 · Other (J): 19,934 · Other (J): 1,771 · Other (J): 209,254 (derivative) · Other (J): 161,807 (derivative) · +2 moreEDGAR
2026-04-294Orchestra BioMed Holdings, Inc. (OBIO)
jointly with WONG RODERICK
Option exercise/expiry (X): 1,250,032 @ $0.00 · Sale (S): 32 @ $4.13 · Option exercise/expiry (X): 1,250,032 (derivative) @ $2.75EDGAR
2026-04-224Kailera Therapeutics, Inc. (KLRA)
jointly with WONG RODERICK
Conversion (C): 10,276,820 · Purchase (P): 500,000 @ $16 · Conversion (C): 8,250,000 (derivative) · Conversion (C): 2,026,820 (derivative)EDGAR
2025-11-134ALLURION TECHNOLOGIES, INC. (ALUR)
jointly with WONG RODERICK, RTW MASTER FUND, LTD., RTW Innovation Master Fund Ltd.
Grant/award (A): 991,544 @ $1.67 · Grant/award (A): 767,848 @ $1.67 · Grant/award (A): 96,896 @ $1.67 · Grant/award (A): 991,544 (derivative) · Grant/award (A): 767,848 (derivative) · Grant/award (A): 96,896 (derivative)EDGAR
2025-11-074ALLURION TECHNOLOGIES, INC. (ALUR)
jointly with WONG RODERICK, RTW MASTER FUND, LTD., RTW Innovation Master Fund Ltd.
Conversion (C): 822,722 @ $3.35 · Conversion (C): 631,954 @ $3.35 · Conversion (C): 37,863 @ $3.35 · Grant/award (A) @ $2,756,117 · Conversion (C) @ $2,756,117 · Grant/award (A) @ $2,117,044 · +3 moreEDGAR
2025-09-234ROCKET PHARMACEUTICALS, INC. (RCKT)
jointly with WONG RODERICK
Option exercise/expiry (X): 1,000,000 @ $40.03 · Other (J): 1,000,000 @ $3.10 · Option exercise/expiry (X): 41,000 @ $19.09 · Other (J): 41,000 @ $3.10 · Option exercise/expiry (X): 59,000 @ $17.81 · Other (J): 59,000 @ $3.10 · +3 moreEDGAR
2025-08-064Orchestra BioMed Holdings, Inc. (OBIO)
jointly with WONG RODERICK
Purchase (P): 3,636,363 (derivative) @ $2.75EDGAR
2025-05-014Orchestra BioMed Holdings, Inc. (OBIO)
jointly with WONG RODERICK
Purchase (P): 49,900 @ $2.99EDGAR
2025-04-294Orchestra BioMed Holdings, Inc. (OBIO)
jointly with WONG RODERICK
Purchase (P): 50,000 @ $2.53EDGAR
2025-04-174ALLURION TECHNOLOGIES, INC. (ALUR)
jointly with WONG RODERICK, RTW MASTER FUND, LTD., RTW Innovation Master Fund Ltd.
Conversion (C): 822,722 @ $3.35 · Conversion (C): 631,954 @ $3.35 · Conversion (C): 37,863 @ $3.35 · Grant/award (A) @ $5,000,000 · Conversion (C) @ $5,000,000EDGAR
2024-12-164ROCKET PHARMACEUTICALS, INC. (RCKT)
jointly with WONG RODERICK
Grant/award (A): 400,000 (derivative) @ $12.49EDGAR
2024-01-164CARGO Therapeutics, Inc. (CRGX)
jointly with WONG RODERICK
Other (J): 1,842,499EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1493215 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →